Mary Rauchenberger

Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial

Katrina M. Pollock, Hannah M. Cheeseman, Alexander J. Szubert et al. · EClinicalMedicine · 2022 · 162 citations · Full text

Pharmacy, Biotechnology, Immunology +16

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial

Ruth Goodall, Sarah Meredith, Andrew Nunn et al. · The Lancet · 2022 · 145 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +11

Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial

Sarah Fidler, Wolfgang Stöhr, Lucy Dorrell et al. · The Lancet · 2020 · 138 citations

Public Health, Infectious Disease Control, Pharmacotherapy +14

Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial

Chris Parker, Nicholas D. James, Chris Brawley et al. · PLoS Medicine · 2022 · 121 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Monophyly and geography of the Río Pánuco Basin swordtails (genus Xiphophorus) with descriptions of four new species. American Museum novitates ; ; no. 2975.

Mary Rauchenberger, Klaus D. Kallman, Donald C. Morizot · American Museum Novitates · 1990 · 102 citations · Full text

Life Sciences, Botany, Zoology +7